The purpose of this study was to explore the relationship between early myocardial injury caused by tumor drug therapy and intestinal microbial structure changes by echocardiographic two-dimensional speckle tracking technique and intestinal microflora structure detection. The investigators will also explore prevention and treatment through randomized controlled trials to initiate early intervention before clinical symptoms appear.
This is a single-center randomized controlled trial in which 100 patients treated with antineoplastic agents will be enrolled. All participants will be followed for 6 months after the initiation of oncology drug therapy. Echocardiography and 2D speckle tracking will be performed and stool and blood samples will be tested before treatment initiation and at 3 and 6 months after initiation. All patients will be randomly divided into test and control groups. Patients in the test group will receive oral Bifidobacterium trivium capsules for 6 months in addition to conventional treatment, whereas patients in the control group will receive conventional antitumor treatment only.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Bifidobacterium Bifidum Oral Capsule for 6 months in addition to conventional treatment
Patients in the control group will receive conventional antitumor treatment only.
Patients in the control group will receive conventional antitumor treatment only.
Peking University Third Hospital
Beijing, China
The decline rate of global longitudinal strain
The primary endpoint is at least a 10% decrease in the global longitudinal strain, determined using cardiac 2D STE.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Patients in the control group will receive conventional antitumor treatment only.
Patients in the control group will receive conventional antitumor treatment only.